Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05078463
Other study ID # UKM PPI/111/8/JEP-2021-578
Secondary ID PRGS/2/2020/TK05
Status Completed
Phase Phase 2
First received
Last updated
Start date September 15, 2021
Est. completion date August 11, 2022

Study information

Verified date August 2022
Source Universiti Kebangsaan Malaysia Medical Centre
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Microneedle (MN) is the mimic of a hypodermic needle, composed of hundreds of micron-sized, out-of-plane protrusions, typically arranged in arrays on a patch that can be applied onto the skin. MN can be fabricated from a variety of materials, preferably biocompatible polymers. Maltose, a natural carbohydrate, is a safe and biocompatible product that can be fabricated into MNs that are biodegradable and soluble within minutes. So far, maltose MN efficacy in enhancing the transdermal drug delivery (TDD) of topical anaesthetic agent such as Eutectic Mixture of Local Anesthetics (EMLA) and thus reducing the pain experienced by paediatric thalassemic patients requiring intravenous cannulation for regular blood transfusion has not been extensively studied. Therefore, the goals of this research are: 1) To compare the VAS score between thalassemic paediatric patients receiving EMLA before IV cannulation for blood transfusion and those receiving EMLA without microneedle application; 2) To compare the skin conductance algesimeter index between those receiving EMLA and microneedle and those receiving EMLA without microneedle application prior to intravenous (IV) cannulation for blood transfusion; 3) To evaluate the agreement between VAS score and the skin conductance algesimeter index obtained via PainMonitor™ machine.


Description:

Read more »
Read more »

Study Design


Related Conditions & MeSH terms


Intervention

Read more »

Locations

Country Name City State
Malaysia Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia (Ukm Medical Centre) Kuala Lumpur Wilayah Persekutuan Kuala Lumpur

Sponsors (3)

Lead Sponsor Collaborator
Universiti Kebangsaan Malaysia Medical Centre Institue of Microengineering and Nanoelectronics (IMEN), Universiti Kebangsaan Malaysia, Universiti Kebangsaan Malaysia Medical Molecular Biology Institute (UMBI)

Country where clinical trial is conducted

Malaysia, 

References & Publications (18)

See more »

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analogue Score (VAS) VAS score is measured in a continuous scale (range 0-100). It is obtained using a Med-05-100 VAS Pain Scale ruler (Schlenker Enterprises Ltd, Lombard, USA) with 0-100 mm slider. It is measured based on the pain experienced on the IV cannulated hand for blood transfusion. Higher VAS score indicates greater intensity or degree of pain whilst lower VAS score indicates lesser pain intensity. The measurements will be made at 1 minute after IV cannulation which will be inserted following EMLA (with or without microneedle) application
Primary Skin Conductance Algesimeter Index The skin conductance peaks per second, measured in microSiemens per second (µS/s), is obtained using PainMonitor™ (Med-Storm Innovation AS, Oslo, Norway) device on the hypothenar eminence of the opposite hand not receiving blood transfusion. Higher skin conductance algesimeter index indicates greater pain intensity and lower values indicate lesser pain intensity. The measurements will be made at 1 minute after IV cannulation which will be inserted following EMLA (with our without microneedle) application
See also
  Status Clinical Trial Phase
Completed NCT03176849 - A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT Phase 4
Recruiting NCT05426252 - Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia Phase 1/Phase 2
Completed NCT03133169 - Erythrocyte Glutamine Level Relation to Pulmonary Hypertension Risk in Beta Thalassemia Major Children
Completed NCT05730374 - Benson's Relaxation Technique, Music Therapy for Children With Thalassemia N/A